Intravaginal Chlamydia trachomatis challenge infection elicits TH1 and TH17 immune responses in mice that promote pathogen clearance and genital tract damage

PLoS ONE

Volumn 11, Issue 9, 2016, Pages

  Vicetti Miguel, Rodolfo D ^a   Quispe Calla, Nirk E ^a   Pavelko, Stephen D ^a   Cherpes, Thomas L ^a  

^a THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 17;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL CLEARANCE; CD4+ T LYMPHOCYTE; CHLAMYDIASIS; CONTROLLED STUDY; EFFECTOR CELL; FEMALE; FEMALE GENITAL SYSTEM; FEMALE GENITAL TRACT INFLAMMATION; FEMALE INFERTILITY; IMMUNE RESPONSE; MOUSE; NONHUMAN; RECURRENT INFECTION; T CELL DEPLETION; TH1 CELL; TH17 CELL; TH2 CELL; TISSUE INJURY; ANIMAL; BAGG ALBINO MOUSE; C57BL MOUSE; CHLAMYDIA TRACHOMATIS; ENDOMETRIUM; FERTILITY; IMMUNITY; IMMUNOLOGY; INFLAMMATION; MICROBIOLOGY; PATHOLOGY; PHYSIOLOGY; REPRODUCTION; UROGENITAL SYSTEM; VAGINA;

ANIMALS; CHLAMYDIA INFECTIONS; CHLAMYDIA TRACHOMATIS; ENDOMETRIUM; FEMALE; FERTILITY; IMMUNITY; INFLAMMATION; MICE, INBRED BALB C; MICE, INBRED C57BL; REPRODUCTION; TH1 CELLS; TH17 CELLS; UROGENITAL SYSTEM; VAGINA;

EID: 84992176707     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0162445     Document Type: Article

References (42)

1. Brunham RC, Rey-Ladino J. Immunology of Chlamydia infection: implications for a Chlamydia trachomatis vaccine. Nat Rev Immunol. 2005; 5: 149-161. PMID: 15688042
2. Peipert JF. Clinical practice. Genital chlamydial infections. N Engl J Med. 2003; 349: 2424-2430. PMID: 14681509
3. Gottlieb SL, Martin DH, Xu F, Byrne GI, Brunham RC. Summary: The natural history and immunobiology of Chlamydia trachomatis genital infection and implications for Chlamydia control. J Infect Dis. 2010; 201(Suppl 2): S190-204. PMID: 20524236
4. Batteiger BE, Tan M. Chlamydia trachomatis (trachoma, genital infections, perinatal infections, and lymphogranuloma venereum). In: Bennett JE, Dolin R, Blaser MJ, editors. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. Saunders, Philadelphia; 2014. pp. 2154-2170.
5. Brunham RC, Pourbohloul B, Mak S, White R, Rekart ML. The unexpected impact of a Chlamydia trachomatis infection control program on susceptibility to reinfection. J Infect Dis. 2005; 192: 1836-1844. PMID: 16235186
6. Wang S, Fan Y, Brunham RC, Yang X. IFN-gamma knockout mice show Th2-associated delayed-type hypersensitivity and the inflammatory cells fail to localize and control chlamydial infection. Eur J Immunol. 1999; 29: 3782-3792. PMID: 10556835
7. Morrison RP, Caldwell HD. Immunity to murine chlamydial genital infection. Infect Immun. 2002; 70: 2741-2751. PMID: 12010958
8. Yeruva L, Spencer N, Bowlin AK, Wang Y, Rank RG. Chlamydial infection of the gastrointestinal tract: a reservoir for persistent infection. Pathog Dis. 2013; 68: 88-95. doi: 10.1111/2049-632X.12052 PMID: 23843274
9. Harris SR, Clarke IN, Seth-Smith HM, Solomon AW, Cutcliffe LT, Marsh P, et al. Whole-genome analysis of diverse Chlamydia trachomatis strains identifies phylogenetic relationships masked by current clinical typing. Nat Genet. 2012; 44: 413-419. doi: 10.1038/ng.2214 PMID: 22406642
10. Coers J, Bernstein-Hanley I, Grotsky D, Parvanova I, Howard JC, Taylor GA, et al. Chlamydia muridarum evades growth restriction by the IFN-gamma-inducible host resistance factor Irgb10. J Immunol. 2008; 180: 6237-6245. PMID: 18424746
11. Morré SA, Lyons JM, Ito JI Jr. Murine models of Chlamydia trachomatis genital tract infection: use of pneumonitis strain versus human strains. Infect Immun. 2000; 68: 7209-7211. PMID: 11203323
12. Vicetti Miguel RD, Harvey SAK, LaFramboise WA, Reighard SD, Matthews DB, Cherpes TL. Human female genital tract infection by the obligate intracellular bacterium Chlamydia trachomatis elicits robust Type 2 immunity. PLoS One. 2013; 8: e58565. doi: 10.1371/journal.pone.0058565 PMID: 23555586
13. Vicetti Miguel RD, Cherpes TL. Hypothesis: Chlamydia trachomatis infection of the female genital tract is controlled by Type 2 immunity. Med Hypotheses. 2012; 79: 713-716. doi: 10.1016/j.mehy.2012.07. 032 PMID: 22986006
14. Vicetti Miguel RD, Maryak SA, Cherpes TL. Brefeldin A, but not monensin, enables flow cytometric detection of interleukin-4 within peripheral T cells responding to ex vivo stimulation with Chlamydia trachomatis. J Immunol Methods. 2012; 384: 191-195. doi: 10.1016/j.jim.2012.07.018 PMID: 22850275
15. Brunham RC, Gottlieb SL, Paavonen J. Pelvic inflammatory disease. N Engl J Med. 2015; 372: 2039-2048. doi: 10.1056/NEJMra1411426 PMID: 25992748
16. Dong X, Liu Y, Chang X, Lei L, Zhong G. Signaling via tumor necrosis factor receptor 1 but not Toll-like receptor 2 contributes significantly to hydrosalpinx development following Chlamydia muridarum infection. Infect Immun. 2014; 82: 1833-1839. doi: 10.1128/IAI.01668-13 PMID: 24549331
17. Ito JI Jr, Harrison HR, Alexander ER, Billings LJ. Establishment of genital tract infection in the CF-1 mouse by intravaginal inoculation of a human oculogenital isolate of Chlamydia trachomatis. J Infect Dis. 1984; 150: 577-582. PMID: 6541671
18. Lyons JM, Morré SA, Airo-Brown LP, Peña AS, Ito JI Jr. Comparison of multiple genital tract infections with Chlamydia trachomatis in different strains of female mice. J Microbiol Immunol Infect. 2005; 38: 383-393. PMID: 16341338
19. Marks E, Tam MA, Lycke NY. The female lower genital tract is a privileged compartment with IL-10 producing dendritic cells and poor Th1 immunity following Chlamydia trachomatis infection. PLoS Pathog. 2010; 6: e1001179. doi: 10.1371/journal.ppat.1001179 PMID: 21079691
20. Gondek DC, Olive AJ, Stary G, Starnbach MN. CD4+ T cells are necessary and sufficient to confer protection against Chlamydia trachomatis infection in the murine upper genital tract. J Immunol. 2012; 189: 2441-2449. doi: 10.4049/jimmunol.1103032 PMID: 22855710
21. Olsen AW, Follmann F, Erneholm K, Rosenkrands I, Andersen P. Protection Against Chlamydia trachomatis Infection and Upper Genital Tract Pathological Changes by Vaccine-Promoted Neutralizing Antibodies Directed to the VD4 of the Major Outer Membrane Protein. J Infect Dis. 2015; pii: jiv137.
22. Dirks JA, Wolffs PF, Dukers-Muijrers NH, Brink AA, Speksnijder AG, Hoebe CJ. Chlamydia trachomatis load in population-based screening and STI-clinics: implications for screening policy. PLoS One. 2015; 10: e0121433. doi: 10.1371/journal.pone.0121433 PMID: 25826298
23. Yu H, Karunakaran KP, Kelly I, Shen C, Jiang X, Foster LJ, Brunham RC. Immunization with live and dead Chlamydia muridarum induces different levels of protective immunity in a murine genital tract model: correlation with MHC class II peptide presentation and multifunctional Th1 cells. J Immunol. 2011; 186: 3615-3621. doi: 10.4049/jimmunol.1002952 PMID: 21296978
24. Yu H, Karunakaran KP, Jiang X, Brunham RC. Evaluation of a multisubunit recombinant polymorphic membrane protein and major outer membrane protein T cell vaccine against Chlamydia muridarum genital infection in three strains of mice. Vaccine. 2014; 32: 4672-4680. doi: 10.1016/j.vaccine.2014. 06.002 PMID: 24992718
25. Morrison RP, Feilzer K, Tumas DB. Gene knockout mice establish a primary protective role for major histocompatibility complex class II-restricted responses in Chlamydia trachomatis genital tract infection. Infect Immun. 1995; 63: 4661-4668. PMID: 7591120
26. Morrison SG, Su H, Caldwell HD, Morrison RP. Immunity to murine Chlamydia trachomatis genital tract infection involves B cells and CD4+ T cells but not CD8+ T cells. Infect Immun. 2000; 68: 6979-6987. PMID: 11083822
27. Andrew DW, Cochrane M, Schripsema JH, Ramsey KH, Dando SJ, O'Meara CP, et al. The duration of Chlamydia muridarum genital tract infection and associated chronic pathological changes are reduced in IL-17 knockout mice but protection is not increased further by immunization. PLoS One. 2013; 8: e76664. doi: 10.1371/journal.pone.0076664 PMID: 24073293
28. Vicetti Miguel RD, Reighard SD, Chavez JM, Rabe LK, Maryak SA, Wiesenfeld HC, Cherpes TL. Transient detection of Chlamydial-specific Th1 memory cells in the peripheral circulation of women with history of Chlamydia trachomatis genital tract infection. Am J Reprod Immunol. 2012; 68: 499-506. doi: 10.1111/aji.12008 PMID: 22934581
29. Van Voorhis WC, Barrett LK, Sweeney YT, Kuo CC, Patton DL. Repeated Chlamydia trachomatis infection of Macaca nemestrina fallopian tubes produces a Th1-like cytokine response associated with fibrosis and scarring. Infect Immun. 1997; 65: 2175-2182. PMID: 9169748
30. Cochrane M, Armitage CW, O'Meara CP, Beagley KW. Towards a Chlamydia trachomatis vaccine: how close are we? Future Microbiol. 2010; 5: 1833-1856. doi: 10.2217/fmb.10.148 PMID: 21155665
31. DeClerq E, Kalmar I, Vanrompay D. Animal models for studying female genital tract infection with Chlamydia trachomatis. Infect Immun. 2013; 81: 3060-3067. doi: 10.1128/IAI.00357-13 PMID: 23836817
32. Vasilevsky S, Greub G, Nardelli-Haefliger D, Baud D. Genital Chlamydia trachomatis: understanding the roles of innate and adaptive immunity in vaccine research. Clin Microbiol Rev. 2014; 27: 346-370. doi: 10.1128/CMR.00105-13 PMID: 24696438
33. Brunham RC. A Chlamydia vaccine on the horizon. Science. 2015; 348: 1322-1323. doi: 10.1126/science.aac6528 PMID: 26089500
34. Stary G, Olive A, Radovic-Moreno AF, Gondek D, Alvarez D, Basto PA, et al. A mucosal vaccine against Chlamydia trachomatis generates two waves of protective memory T cells. Science. 2015; 348: 1331, aaa8205.
35. Råberg L, Sim D, Read AF. Disentangling genetic variation for resistance and tolerance in infectious diseases in animals. Science. 2007; 318: 812-814. PMID: 17975068
36. Medzhitov R, Schneider DS, Soares MP. Disease tolerance as a defense strategy. Science. 2012; 335: 936-941. doi: 10.1126/science.1214935 PMID: 22363001
37. Soares MP, Gozzelino R, Weis S. Tissue damage control in disease tolerance. Trends Immunol. 2014; 35: 483-494. doi: 10.1016/j.it.2014.08.001 PMID: 25182198
38. Vicetti Miguel RD, Hendricks RL, Aguirre AJ, Melan MA, Harvey SA, Terry-Allison T, St Leger AJ, Thomson AW, Cherpes TL. Dendritic cell activation and memory cell development are impaired among mice administered medroxyprogesterone acetate prior to mucosal herpes simplex virus type 1 infection. J Immunol. 2012; 189: 3449-3461. PMID: 22942424
39. Lena S, Pourbohloul B, Brunham RC. Effect of immune response on transmission dynamics for sexually transmitted infections. J Infect Dis. 2005; 191: S78-84. PMID: 15627234
40. Bernstein-Hanley I, Balsara ZR, Ulmer W, Coers J, Starnbach MN, Dietrich WF. Genetic analysis of susceptibility to Chlamydia trachomatis in mouse. Genes Immun. 2006; 7: 122-129. PMID: 16395389
41. Vicetti Miguel RD, Henschel KJ, Dueñas Lopez FC, Quispe Calla NE, Cherpes TL. Fluorescent labeling reliably identifies Chlamydia trachomatis in living human endometrial cells and rapidly and accurately quantifies chlamydial inclusion forming units. J Microbiol Methods. 2015; 119: 79-82. doi: 10.1016/j. mimet.2015.10.003 PMID: 26453947
42. Schneider CA, Rasband WS, Eliceiri KW. NIH Image to ImageJ: 25 years of image analysis. Nat Methods. 2012; 9: 671-675. PMID: 22930834